Tectonic Therapeutic
TECX
40 hedge funds and large institutions have $18.9M invested in Tectonic Therapeutic in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 13 closing their positions.
0.55% less ownership
Funds ownership: 4.32% → 3.77% (-0.55%)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
17% less funds holding
Funds holding: 48 → 40 (-8)
17% less capital invested
Capital invested by funds: $22.8M → $18.9M (-$3.9M)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.51M |
| 2 |
Morgan Stanley
New York
|
+$797K |
| 3 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$241K |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$126K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$28.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.09M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
-$1.83M |
| 3 |
BlackRock
New York
|
-$716K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$650K |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$648K |
TECX Hedge Fund Activity: Q2 2023 in Review
40 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q2 2023, worth a combined $18.9M — down 17% from $22.8M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of TECX and 5 opened new positions — a net loss of 8 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Tang Capital Management, adding an estimated $2.51M. The largest seller was Farallon Capital Management, cutting an estimated $2.09M.
- 40 institutional investors held Tectonic Therapeutic (TECX) as of Q2 2023, down from 48 in Q1 2023.
- Funds reported $18.9M of Tectonic Therapeutic stock for Q2 2023, down 17% quarter-over-quarter.
- 5 funds opened new Tectonic Therapeutic positions in Q2 2023 and 13 closed out, a net change of -8 holders.
- The largest Tectonic Therapeutic buyer in Q2 2023 was Tang Capital Management, an estimated $2.51M added.
- The largest Tectonic Therapeutic seller in Q2 2023 was Farallon Capital Management, an estimated $2.09M sold.
Based on aggregated 13F filings for Q2 2023.